Literature DB >> 25851065

Research Synthesis and the Value per Statistical Life.

Lisa A Robinson1, James K Hammitt1.   

Abstract

The value of small changes in mortality risk, conventionally expressed as the value per statistical life (VSL), is a major determinant of the benefits of many environmental, health, and safety regulations and other policies. However, selecting an appropriate value is challenging. Different studies yield different results and analysts often find they lack estimates that are directly applicable to the policy they are assessing. Research-synthesis methods are widely used to address these concerns in many fields, yet we find only limited applications to estimating VSL. More structured, criteria-driven review of the available studies is an important first step. Additional meta-analyses that use such review as a starting point are needed to explore variation across studies as well as to adjust estimates to better fit different policy contexts. Carefully designed expert elicitation is significantly underutilized and is particularly important when the available research is limited or inconsistent. Although greater use of such methods is likely to enhance the credibility of the VSL estimates applied in policy analyses, as well as provide greater insights into the advantages and limitations of the available research, it is not clear how much the resulting estimates will vary from those currently used. In the United States, these estimates are generally around $9 million.
© 2015 Society for Risk Analysis.

Keywords:  Benefit-cost analysis; health risk valuation; value per statistical life; willingness to pay

Year:  2015        PMID: 25851065     DOI: 10.1111/risa.12366

Source DB:  PubMed          Journal:  Risk Anal        ISSN: 0272-4332            Impact factor:   4.000


  4 in total

1.  Economics in "Global Health 2035": a sensitivity analysis of the value of a life year estimates.

Authors:  Angela Y Chang; Lisa A Robinson; James K Hammitt; Stephen C Resch
Journal:  J Glob Health       Date:  2017-06       Impact factor: 4.413

2.  Differential discounting in the economic evaluation of healthcare programs.

Authors:  Jürgen John; Florian Koerber; Mareike Schad
Journal:  Cost Eff Resour Alloc       Date:  2019-12-17

3.  [Impact of physical inactivity on mortality and the economic costs of cardiovascular deaths: evidence from Argentina].

Authors:  Christian Martín García; José Antonio González-Jurado
Journal:  Rev Panam Salud Publica       Date:  2017-08-21

4.  Do the Benefits of COVID-19 Policies Exceed the Costs? Exploring Uncertainties in the Age-VSL Relationship.

Authors:  Lisa A Robinson; Ryan Sullivan; Jason F Shogren
Journal:  Risk Anal       Date:  2020-07-16       Impact factor: 4.302

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.